DAC for "Detection of Gene Fusions using Targeted Next-Generation Sequencing – a Comparative Evaluation"

Request Access

Dataset ID	Description	Technology	Samples
EGAD00001006913	Five commercially available parallel sequencing assays were evaluated for their ability to detect gene fusions in eight cell lines and 18 FFPE tissue samples carrying a variety of known gene fusions. Four RNA-based assays and one DNA-based assay were compared; two were hybrid capture-based, TruSight Tumor 170 Assay (Illumina) and SureSelect XT HS Custom Panel (Agilent), and three were amplicon-based, Archer FusionPlex Lung Panel (ArcherDX), QIAseq RNAscan Custom Panel (Qiagen) and Oncomine Focus Assay (Thermo Fisher Scientific).	Illumina MiSeq Ion Torrent S5 NextSeq 500	228